Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jul 6, 2012 (14 years ago)

Hydroxyzine Hydrochloride Oral Solution

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Impurities/Degradation Products: High Out of Specification results for a known impurity resulted at the 12-month room temperature time point.

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

HYDROXYZINE HYDROCHLORIDE ORAL SOLUTION, USP, 10 mg/5 mL, 1 PINT (473 mL) bottle, Rx only, Mfg. for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-1310-58, UPC 3 0603-1310-58 4.

Affected NDC 0603-1310-58

Compare with the code on your package — it is the most precise check available.

Drug: Hydroxyzine

Recalling firm
Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals
NDC code
0603-1310-58
Origin
AL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1417-2012 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Hydroxyzine recalls

See all
Class II · Moderate risk

Hydroxyzine Hydrochloride Oral Solution

Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, 4-chorobenzophenone, and for total impurities.

Terminated Impurity / degradation Morton Grove Pharmaceuticals, Inc. NDC 60432-150-04 D-0174-2021
Class II · Moderate risk

HydrOXYzine HYDROCHLORIDE SYRUP

CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.

Terminated Impurity / degradation Lannett Company, Inc. NDC 54838-502-80 D-0083-2019

Other recalls by Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals

All 2012 recalls
Class III · Low risk

Hydrocortisone Lotion

Superpotent Drug: above specification for the assay.

Terminated Wrong potency / content Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals NDC 0603-7785-52 D-0859-2017
Class III · Low risk

Dexamethasone Elixir

Failed Impurities/ Degradation Specifications

Terminated Impurity / degradation Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals NDC 0603-1147-56 D-0438-2017
Class III · Low risk

Ranitidine Syrup

Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben.

Terminated Stability / shelf life Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals D-0162-2016